TG Therapeutics TGTX CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's capex?
- TG Therapeutics (TGTX) reported capex of $51K in Q1 2026.
- How has TG Therapeutics's capex changed year-over-year?
- TG Therapeutics's capex increased by 104.0% year-over-year, from $25K to $51K.
- What is the long-term trend for TG Therapeutics's capex?
- Over 3 years (2021 to 2025), TG Therapeutics's capex has grown at a -18.9% compound annual growth rate (CAGR), from $401K to $214K.
- What does capex mean?
- Cash spent on physical assets like buildings, machinery, or equipment.
- How do you interpret capex?
- Lower expenditures may signal capital efficiency, while higher expenditures indicate growth-oriented investment.
- How does capex compare across companies?
- Varies widely by industry; capital-intensive firms have high ratios relative to revenue.